Canaan X L.P. Protagonist Therapeutics, Inc (PTGX) insider trading activity

PTGX Quotes by TradingView

Canaan X L.P. is > 10% Shareholder of Protagonist Therapeutics, Inc. Currently has a direct ownership of 2.12 Million shares of PTGX, which is worth approximately $88.9 Million. The most recent transaction as insider was on May 17, 2018, when has been sold 38,968 shares (Common Stock) at a price of $6.09 per share, resulting in proceeds of $237,315. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.12M
0% 3M change
0% 12M change
Total Value Held $88.9 Million

CANAAN X L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2018
SELL
Open market or private sale
$237,315 $6.09 p/Share
38,968 Reduced 1.81%
2,116,552 Common Stock
May 16 2018
SELL
Open market or private sale
$190,189 $6.46 p/Share
29,441 Reduced 1.35%
2,155,520 Common Stock
May 15 2018
SELL
Open market or private sale
$373,993 $6.48 p/Share
57,715 Reduced 2.57%
2,184,961 Common Stock
May 14 2018
SELL
Open market or private sale
$494,255 $6.37 p/Share
77,591 Reduced 3.34%
2,242,676 Common Stock
Mar 23 2018
SELL
Open market or private sale
$1,241,564 $20.71 p/Share
59,950 Reduced 2.52%
2,320,267 Common Stock
Mar 22 2018
SELL
Open market or private sale
$98,131 $20.62 p/Share
4,759 Reduced 0.2%
2,380,217 Common Stock
Mar 21 2018
SELL
Open market or private sale
$364,776 $20.61 p/Share
17,699 Reduced 0.74%
2,384,976 Common Stock
Mar 20 2018
SELL
Open market or private sale
$351,607 $20.61 p/Share
17,060 Reduced 0.71%
2,402,675 Common Stock
Mar 19 2018
SELL
Open market or private sale
$276,440 $20.57 p/Share
13,439 Reduced 0.55%
2,419,735 Common Stock
Mar 16 2018
SELL
Open market or private sale
$142,052 $20.51 p/Share
6,926 Reduced 0.28%
2,433,174 Common Stock
Mar 15 2018
SELL
Open market or private sale
$242,541 $20.64 p/Share
11,751 Reduced 0.48%
2,440,100 Common Stock
Mar 14 2018
SELL
Open market or private sale
$4,154 $20.77 p/Share
200 Reduced 0.01%
2,451,851 Common Stock
Mar 13 2018
SELL
Open market or private sale
$25,091 $20.84 p/Share
1,204 Reduced 0.05%
2,452,051 Common Stock

Also insider at

IDYA
IDEAYA Biosciences, Inc. Healthcare
> 10% Shareholder
ASTR
Astra Space, Inc. Industrials
> 10% Shareholder
NXTC
NextCure, Inc. Healthcare
> 10% Shareholder
ITRM
Iterum Therapeutics plc Healthcare
Director
CXL

Canaan X L.P.

> 10% Shareholder
Westport, CT

Track Institutional and Insider Activities on PTGX

Follow Protagonist Therapeutics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

News

Receive news related to Protagonist Therapeutics, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTGX